None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) 20 ~ 55 year old male and female adults 2) Those diagnosed with PTSD according to the SCID-5 (Structured Clinical Interview for DSM-5) criteria 3) Trauma occurred more than 6 months 4) Those who voluntarily agreed to participate after receiving explanation of the purpose and process of this clinical trial
Exclusion criteria
Exclusion criteria: 1) Those with a severef mental illness ? Who has a recent or past delusion or hallucination ? At least one manic episode appears ? Who has a alcohol abuse or dependency history ? Those who are at risk of suicide 2) If it is necessary to continuously administer a substance that is thought to have an effect on symptom induction, excluding concomitant medication 3) Those who have serious problems with congenital diseases, central nervous system, peripheral nervous system diseases, endocrine diseases, immunological diseases, heart, liver and kidney system 4) Those who are pregnant or lactating 5) Those who have participated in other clinical studies for the past month or are currently participating in other clinical studies. 6) Those who are deemed difficult to carry out the clinical trial by clinical reserarcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5-K) | — |
Secondary
| Measure | Time frame |
|---|---|
| Impact of Event Scale-Revised (IES-R-K);The Clinical Global Impression–Improvement scale (CGI-I);Beck Anxiety Inventory (BAI);Beck Depression Inventoy (BDI);Insomnia severity index (ISI);Hwabyung Score;The Core Seven-Emotions Inventory Short Form (CSEI-S);Quantative encephalogram (QEEG);Mentalizing the Rooms of Mind (MRM);Economic analysis;Safety assessment | — |
Countries
Korea, Republic of
Contacts
Wonkwang University Sanbon Hospital